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Study Design. General population utility valuation study.
Objective. The aim of this study was to develop a technique
for calculating utilities from the Spine Oncology Study Group
Outcomes Questionnaire v2.0 (SOSGOQ2.0).
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Summary of Background Data. The ability to calculate
quality-adjusted life-years (QALYs) for metastatic spine disease
would enhance treatment decision-making and facilitate economic analysis. QALYs are calculated using utilities.
Methods. Using a hybrid concept-retention and factorial analysis shortening approach, we first shortened the SOSGOQ2.0 to
eight items (SOSGOQ-8D). This was done to lessen the cognitive burden of the utility valuation exercise. A general population sample of 2730 adults was then asked to evaluate 12
choice sets based on SOSGOQ-8D health states in a Discrete
Choice Experiment. A utility scoring rubric was then developed
using a mixed multinomial-logit regression model.
Results. We were able to reduce the SOSGOQ2.0 to an
SOSGOQ-8D with a mean error of 0.003 and mean absolute
error of 3.078 compared to the full questionnaire. The regression
model demonstrated good predictive performance and was used
to develop a utility scoring rubric. Regression results revealed
that participants did not regard all SOSGOQ-8D items as
equally important.
Conclusion. We provide a simple technique for converting the
SOSGOQ2.0 to utilities. The ability to evaluate QALYs in
metastatic spine disease will facilitate economic analysis and
patient counseling. We also quantify the importance of individual
SOSGOQ-8D items. Clinicians should heed these findings and offer
treatments that maximize function in the most important items.
Key words: decision-making, health economics, health services
research, heath related quality-of-life, neoplasm metastasis,
quality of life, quality-adjusted life years, resource allocation,
spinal neoplasms, spine, survey, surveys and questionnaires,
utilities.
Level of Evidence: 3
Spine 2021;46:1165–1171

T

reatment decisions for spine metastases, the most
common site of skeletal metastases, are challenging
because multiple patient and treatment-related factors including performance status, survival and risk of
adverse events, must be considered.1 Furthermore, with
www.spinejournal.com
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limited life expectancy and scarce resources, the value of
care in these patients is hotly debated.2,3 Due to this controversy the economic value of metastatic spine care is
desperately needed.4,5 The ability to calculate qualityadjusted life-years (QALYs) for metastatic spine disease
would facilitate economic analysis and thus enhance treatment decision-making and resource utilization.
QALYs are required in economic analysis because economic decisions are based on the incremental cost-effectiveness ratio which is simply the cost per QALY gained.6
QALY analysis could also help patients and clinicians
jointly assess the trade-offs between survival, health-related
quality-of-life (HRQoL) benefits, recovery, and potential
complications to reach an optimal treatment decision.6,7
QALYs are calculated using utilities which are a number,
typically between 0 and 1, that quantifies the preference for
(i.e., desirability of) a health state.6 The utility of perfect
health is set at 1 and the utility of dead is set at 0. Studies on
metastatic spine disease have calculated utilities by converting to generic health measure responses (e.g., the EQ-5D,
SF-6D, and HUI-3) to utilities using multiattribute utility
functions (MAUFs).
Literature examining the economic value of treatments
for spinal metastases has been inconclusive. Uncertainty
regarding the economic value of treating metastatic spine
disease may be a consequence of psychometric limitations of
generic health measures, which demonstrate suboptimal
validity and responsiveness in conditions relevant to spinal
metastases: cancer, spinal cord injury, and musculoskeletal
disorders.6,8–13 In an effort to improve HRQoL assessments
in patients with metastatic spine disease, the AO Spine
Knowledge Forum Tumor (former Spine Oncology Study
Group, SOSG) developed, revised, and validated a spine
oncology-specific outcome questionnaire (SOSGOQ2.0).14
However, since a MAUF has not been developed for the
SOSGOQ2.0, this outcome measure cannot be used to
calculate QALYs.
We report the development of a MAUF for the SOSGOQ2.0. We first performed shortening of the SOSGOQ2.0
to eight items (SOSGOQ-8D) which was needed to minimize
the cognitive burden of the utility valuation exercise.6 We
then conduct a utility valuation exercise to develop and
validate a MAUF for the SOSGOQ-8D using a Discrete
Choice Experiment (DCE) with a general population sample.

MATERIALS AND METHODS
Descriptive System
A hybrid concept-retention and factorial analysis approach
was used for shortening the SOSGOQ2.0 to the SOSGOQ8D.15,16 To maintain content validity and clinical relevance,
we planned to retain all four neurologic function single
questions (Neurologic:Legs, Neurologic:Arms, Neurologic:Bladder, and Neurologic:Bowel). Therefore, it was necessary to select a single item from each of the remaining four
domains (Physical Function, Pain, Mental Health, Social
Function) in the SOSGOQ2.0 to achieve an eight item
1166
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questionnaire. The full analysis is reported in Supplemental
Digital Content 1, Text, http://links.lww.com/BRS/B730.
The optimal SOSGOQ-8D questions for the non-neurologic domains were: items 3 (self-care), 11 (average pain), 17
(anxiety), 19 (personal relationships). These items were
included in the final SOSGOQ-8D which is shown in Table 1.

Subjects
Participants were recruited from an online market research
panel (Toluna Influencers).17 Quota sampling was used to
ensure that the study sample was representative of the
general United States population in terms of region, gender,
and age based on 2017 United States Census Bureau Population Estimates Program data.18 The utility valuation protocol was submitted for IRB review and deemed exempt

Health States
The SOSGOQ-8D was converted to a set of health states
consisting of eight attributes corresponding to each of the
SOSGOQ-8D items and (the duration of survival in the
given health state.19 SOSGOQ-8D rating level phrasing was
used in the health state descriptions. Duration of survival
was set at: 1 year, 2 years, 5 years, and 10 years.20 Health
states were phrased in the second person and structured as
declarative sentences.21

Discrete Choice Experiment Valuation Task
Utility valuation was conducted using a DCE questionnaire.
DCE methodology is simpler than traditional utility valuation and is therefore better suited for online studies.22,23 In
the DCEs for this study, participants were presented with
pairs of health states (choice sets) and asked to select the
more desirable health state. Choice sets were be presented in
a table with differing attributes highlighted (Figure 1).20

Choice Set Selection
To select a manageable subset of choice sets, we first
removed clinically unrealistic health states to form a pool
of clinically relevant health states. Next, to lessen the
cognitive burden of the DCEs, choice sets were developed
in which no more than five attributes differed between
health states.20 A D-efficient collection of 100 nondominated choice sets was organized into blocks of 10 blocks
using the modified Federov algorithm with Ngene software
(Supplemental Digital Content 6, Table, http://links.lww.com/BRS/B735).22,24 The design was developed using
parameter values from a general population utility valuation
study for a cancer-specific quality of life questionnaire using
DCE methodology.20 To assess whether participants understood the DCE task, one dominated choice set (one health
state is clearly preferable) was added to each block to test for
logic. To assess whether participants engaged in the DCE
task, one choice set was repeated in each block, but with
health state order reversed to test for internal consistency.
Therefore, there were a total of 12 choice sets in each block.
There were three levels of randomization in the survey. First,
participants were randomized to one of the 10 blocks.
September 2021
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TABLE 1. The Eight-item Spine Oncology Study Group Outcomes Questionnaire
Domain (Abbreviation)
Physical Function (PF)

Neurologic: Legs (L)

Neurologic: Arms (A)

Neurologic: Bowel (Bow)

Neurologic: Bladder (Blad)

Pain (P)

Mental Health (MH)

Social Function (SF)

Level
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5

Stem

Descriptor

Your spine limits your ability to care for yourself. . .

Not at all
A little bit
Somewhat
Quite a bit
Very much
You have weakness in your legs. . .
None
Mild occasionally
Mild constantly
Moderate constantly
Severe constantly
You have weakness in your arms. . .
None
Mild occasionally
Mild constantly
Moderate constantly
Severe constantly
You have difficulty controlling your bowel function beyond Never
episodes of diarrhea/constipation. . .
Rarely
Sometimes
Often
Very often
You have difficulty controlling your bladder function. . .
Never
Rarely
Sometimes
Often
Need a catheter
On average, your back/neck pain is. . .
None
Very mild
Mild
Moderate
Severe
You feel anxious about your health related to your spine. . . Never
Rarely
Sometimes
Often
Very often
Your spine condition affects your personal relationships. . . Never
Rarely
Sometimes
Often
Very often

Second, the order choice set in each block was randomized.
Finally health state order was randomized in each choice set.

website closed by asking patients to provide five-point Likert
rating for the statement ‘‘[t]his survey was difficult.’’

Survey Procedures

Statistical Analysis

The market research company sent panel members an e-mail
invitation to participate in our study. Interested panel members
were redirected to a secure website hosting the utility valuation
exercise.17,21 Participants first read brief background information on metastatic spine disease. Next, participants were
provided with an explanation of DCEs and shown a worked
example. Participants then completed a practice DCE and
provided feedback before completing the study DCEs. The

Participants who spent an average of at least eight seconds
per choice set; selected the clearly dominant alternative in
the dominated choice; and provided consistent responses for
the repeat choice set were deemed to have engaged in and
understood the DCE tasks. Only these participants were
included in analyses.17,19,25
A multiattribute utility function was estimated from DCE
responses using a mixed multinomial-logit regression model

Spine
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Figure 1. Choice set presentation in online Discrete Choice Experiment. Differing attributes highlighted in green.

(MIXL) using the ‘‘mixl’’ library in the statistical programming language R.19,26–29 The regression model incorporated
the main survival duration effect, and two-way interactions
between survival duration and each SOSGOQ-8D item.19
Each parameter was treated as a random effect to account for
participant heterogeneity in the repeated DCE tasks. The
random effects were modeled with 1000 draws from a normal
distribution. In the base regression model, all SOSGOQ-8D
items were coded as nominal categorical (dummy) predictors
to avoid assumptions of linear or extra-linear effects. The base
regression model was simplified by removing nonsignificant
predictors, and combining adjacent predictors to maintain a
monotonic decreasing relationship. Model performance during the simplification procedure was monitoring using
McFadden’s r2.30 Values between 0.2 and 0.4 indicate very
good model fit and are analogous to an R2 value between 0.7
and 0.9 for linear regression.
In an effort to strengthen the generalizability of the
regression analysis, we implemented validation by allocating participants to a training set and validation set in a 3:1
ratio.31 Regression models were fit using only the training
set. The performance of the simplified regression model was
assessed by prediction accuracy for choice set selections by
participants in the validation set using 1000 draws from the
MIXL model. Prediction accuracy was quantified using the
area under the curve (AUC) interpreted using the following
thresholds: excellent, 0.9 to 1; good, 0.8 to 0.9; fair, 0.7 to
0.8; poor, 0.6 to 0.7; and failed, 0.5 to 0.6.32
Regression coefficients quantify the impact of dysfunction in a particular SOSGOQ-8D item on utility. Since level
1168
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1 for all SOSGOQ-8D items is nondysfunctional, this level
imparts no change in utility. Under this scheme, utilities can
be calculated by substituting the sum of the product of
predictors and coefficients for each SOSGOQ-8D item in
the formula
Utility ¼ 1  PF  L  A  Bow  Blad  P  MH  SF :
(1)
A worked example is provided in the Results section.
Since, the MIXL model treats each coefficient as a normal
(‘‘bell-curve’’) random variable, regression results consisted
of a mean and standard deviation for each coefficient. In this
way MIXL techniques model heterogeneity (differences
between individuals) of the utility impact of dysfunction
in the SOSGOQ-8D items. Thus to predict how a single
individual values the utility of each SOSGOQ-8D item, a
random draw is made from the normal distributions estimated by the MIXL model. The mean coefficient values are
the expected values for a single individual. In accordance
with best practices in health economics, a SOSGOQ-8D
utility scoring rubric was developed using mean values.6 The
importance of individual SOSGOQ-8D items was quantified by calculating the difference in utilities between the best
and worst levels of the attribute.33

Sample Size Calculation
Sample size was guided by S-efficiency which is a measure of
the minimum sample size to estimate statistically significant
regression parameters at the 95% level.34 The minimum
September 2021
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sample for the DCE design shown in Supplemental Digital
Content 6, Table is 2039 participants, http://links.lww.com/
BRS/B735. Since we partitioned data in a 3:1 ratio, the
sample size for the training set was 2039, and for the
validation set was 691.

RESULTS
Of the participants who began the DCE exercise, 95.3%
completed the task. All geographic, sex, and age quotas
based on the 2017 United States Census Bureau Population
Estimates Program were met.18 There were no statistically
or qualitatively significant differences between the training
set and validation set in terms of sex, age, or census region
(Table 2). Most of the participants in the training and
validation sets (69% and 70%, respectively) did not agree
with the statement that ‘‘this survey was difficult.’’
Five pairs of adjacent coefficients were collapsed to
simplify the base regression model: L2 and L3, A1 and
A2, MH1 and MH2, MH2 and MH3, and SF3 and SF4.
Model simplification did not have an adverse effect on
performance with the training set as McFadden’s r2
remained unchanged at 0.26 which is indicative of an
excellent fit. The simplified regression model had excellent
external validity as it predicted DCE choices in the validation set well with an AUC of 0.82 (95% confidence interval
[CI]: 0.81–0.83).
The final MIXL regression results are shown in Supplemental Digital Content 7, Table, http://links.lww.com/BRS/
B736. Statistically significant standard deviation for the
majority of coefficients indicated the presence of heterogeneity between participants; therefore, use of a MIXL model
was appropriate. Regression results revealed that participants did not regard all SOSGOQ-8D items equally important. The rank order of importance scores for the mean
coefficient values (decreasing) was: Neurologic:Bowel/ Neurologic:Bladder, Pain, Physical Function/Neurologic:Legs,
Social Function, Neurologic:Arms, and Mental Health.

To calculate utilities with Eq. (1), utility values for each
item are obtained from the scoring rubric shown in Table 3.
SOSGOQ-8D responses must first be converted to numerical levels using Table 1. To illustrate the use of Eq. (1) and
the scoring rubric, we will calculate the utility for Patient A
who provided the SOSGOQ-8D responses: PF5, L3, A2,
Bow1, Blad1, P4, MH4, SF5. For the PF domain, Patient A
provided a rating of 5, the corresponding number in Table 2
is 0.35. For the L domain, the patient provided a rating of 3,
the corresponding number is Table 2 is 0.05. This process is
repeated for each domain and the values substituted into the
Equation 1
Utility ¼ 1 0:35 0:05 0 0 0:15 0:04 0:26 ¼ 0:15:

DISCUSSION
In this article, we expanded the use of the SOSGOQ2.0 to
QALY calculation. In Part 1 we formally shortened the
SOSGOQ2.0 to an eight-item SOSGOQ-8D questionnaire.16
This step was necessary to lessen the cognitive burden of the
utility valuation exercise which was reported in Part2.
We quantified a MAUF for the SOSGOQ-8D for the US
general population using DCE methods. The MAUF demonstrated good out-of-sample prediction accuracy with an
AUC of 0.82 (95% CI: 0.81–0.83). We provided a worked
example for a hypothetical patient to illustrate how to
calculate utilities using Eq. (1) and Table 3. This utility
value quantifies the desirability of Patient A’s health state
relative to perfect health (PF1, L1, A1, Bow1, Blad1, P1,
MH1, SF1) from the general population perspective. A
utility of 0.15 means that the general population would
regard 365 days of life in Patient A’s health as equivalent to
365 days  0.15 ¼ 55 days of life in perfect health. In other
words, if given the option between living 1 year in Patient
A’s health state, or only living 55 days in perfect health, on
average, members of the general population would choose

TABLE 2. Respondent Demographic Characteristics
Sex, no. (%)
Female
Male
Age, y, no. (%)
18–29
30–39
40–49
50–59
60–69
70
Census region, no. (%)
Northeast
Midwest
South
West
Spine

Training Set, N ¼ 2039

Validation Set, N ¼ 691

1034 (51)
1005 (49)

366 (53)
325 (47)

434
358
325
356
299
267

(21)
(18)
(16)
(17)
(15)
(13)

153
112
114
115
98
99

(22)
(17)
(16)
(17)
(14)
(14)

364
412
771
492

(18)
(20)
(38)
(24)

120
155
263
153

(17)
(22)
(38)
(23)

www.spinejournal.com
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TABLE 3. SOSGOQ-8D Utility Scoring Rubric
Level
PF
1
2
3
4
5

0
0.09
0.15
0.28
0.35

L

A

0
0.05
0.05
0.13
0.31

0
0
0.09
0.09
0.24

SOSGOQ-8D Item
Bow
Blad
0
0.06
0.16
0.32
0.39

0
0.05
0.12
0.24
0.38

P

MH

SF

0
0.05
0.13
0.15
0.36

0
0
0.04
0.04
0.10

0
0.06
0.06
0.18
0.26

To use this table, SOSGOQ-8D responses must converted to numerical levels using Table 1. The appropriate values from this table are then substituted in Eq.
(1) to calculate utilities. A indicates Arms; Blad, bladder; Bow, bowel; L, Legs; MH, Mental Health; P, Pain; PF, Physical Function; SF, Social Function.

to live a shorter duration with better health. The SOSGOQ8D MAUF also provides useful insights for clinicians.
The MAUF can also be used to quantify the importance of
each SOSGOQ-8D item. Importance scores are listed in
Table 3 and quantify the how much individuals discount
life in the worst level of each SOGOQ-8D item relative to
the best. For example, an importance score 0.33 for both
sphincter function domains means that individuals would be
willing to trade 365 days  0.33 ¼ 120 days of life to reverse
sphincter dysfunction from its worst state. In contrast,
individuals are only willing to trade 365 days 
0.15 ¼ 55 days of life to reverse arm dysfunction from its
worst state. Notably, lower extremity neurologic function,
which is a common outcome for metastatic spine disease
studies, was less important than sphincter function and pain.
It was equally important to physical function which was
represented by the ability to care for self. Clinicians should
heed these findings and offer treatments that maximize
function in the most important attributes.
In Part 1 we formally shortened the SOSGOQ2.0 to an
eight-item SOSGOQ-8D questionnaire using the ‘‘datasplitting’’ technique for internal validation.35,36 Based on
a priori selection criteria, SOSGOQ2.0 items 3, 11, 17, and
19 were selected because these items performed best on the
validation set. Other decision rules for internal validation
yield different sets of items. For example, items 4, 13, 17 and
18 were the best performing on the training set and were the
second-best on the validation set. An independent test set, in
addition to the training and validation sets used, would be
required to evaluate different decision rules. Since the SOSGOQ-8D identified in this study have clinical face validity,
we feel it is appropriate to use them in future work without
further validation with an additional test set.
It is important for readers to appreciate that utilities
provided by the general population (ex ante) are not equivalent to utilities obtained from patients who have experienced the health states of interest (ex post).37 Although ex
ante utilities are theoretically restricted to system policy
decisions, ex ante utilities have become the de facto standard
for individual patient decision making. This is because the
widely used utilities obtained from generic health surveys
such as the EuroQol-5D, Short Form-6D, and Health Utilities Index 3 are actually ex ante valuations.6 Therefore
generating ex ante utilities for the SOSGOQ-8D conforms
with conventions in the literature.
1170
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We expanded the use of the SOSGOQ2.0 to QALY
calculation. Eq. (1) and Table 3 can be used together to
covert SOSGOQ-8D responses to utilities. The regression
modeling exercise revealed the relative importance of SOSGOQ-8D items to the general population. These data can be
used to help inform population level health care decisionmaking, such as the allocation of limited resources for
specific treatments. The results of this study can also help
clinicians counsel patients.
Supplemental Digital Content 2, http://links.lww.com/
BRS/B731.
Supplemental Digital Content 3, http://links.lww.com/
BRS/B732.
Supplemental Digital Content 4, http://links.lww.com/
BRS/B733.
Supplemental Digital Content 5, http://links.lww.com/
BRS/B734.

Key Points
Consideration of QALYs can enhance resource
allocation and patient counseling.
We developed a simple technique for converting
the SOSGOQ to QALYs weights (utilities)
Respondents did regard all SOSGOQ domains
equally important; therefore, clinicians should
heed these findings and offer treatments that
maximize function in the most important domains.
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